Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth ...

In the summer of 2022, at least 70 children in Gambia died from kidney failure after using cough medicine made by India-based Maiden Pharmaceuticals that contained ethylene glycol and diethylene ...

Opportunities in traditional pharma companies with a focus on domestic formulations and US generics are drying up because of ...

In an exclusive interview with Business Today, D. Sridhar Babu, Minister for Information Technology, Industries and Commerce, ...

India-UK FTA excludes patent term extensions and data exclusivity, safeguarding Indian generic drug industry interests.

PharmaHopers explains the booming Indian pharma distributorship market, driven by rising demand, tech adoption, and ...

India imposes about 10% tax on pharma imports from the U.S. while paying nearly no tariff for its exports to the country, according to industry experts. India sells about 65% of all generic drugs ...

The deal eliminates tariff barriers and aims to ease regulatory processes, creating room for Indian companies to expand in ...

The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India’s Pharma MedTech sector from cost- to ...

India has the highest number of U.S. Food and Drug Administration-approved pharmaceutical plants outside of the U.S., and pharmaceutical exports from India accounted for nearly $30 billion last year.

The pharmaceutical industry in North India is poised for a major churn during the year, with the micro, small and medium units (MSME), which accounts for a majority in numerical strength, struggling ...

More than 500 active pharmaceutical ingredients (APIs) are produced in India, supplying 60,000 generic brands. India now has the third-largest API market in the world as a result.